Page last updated: 2024-08-21

durapatite and luteolin

durapatite has been researched along with luteolin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, Y; Qin, A; Song, F; Tickner, J; Wei, C; Xu, J; Yang, M; Zhao, J; Zhou, L	1

Other Studies

1 other study(ies) available for durapatite and luteolin

Article	Year
Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades. Journal of cellular physiology, 2018, Volume: 233, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Calcium Signaling; Disease Models, Animal; Dose-Response Relationship, Drug; Durapatite; Glucosides; Lipopolysaccharides; Luteolin; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteolysis; RANK Ligand; RAW 264.7 Cells; Skull; Time Factors	2018

Article

Year

Luteoloside prevents lipopolysaccharide-induced osteolysis and suppresses RANKL-induced osteoclastogenesis through attenuating RANKL signaling cascades.

Journal of cellular physiology, 2018, Volume: 233, Issue:2

Topics: Animals; Anti-Inflammatory Agents; Calcium Signaling; Disease Models, Animal; Dose-Response Relationship, Drug; Durapatite; Glucosides; Lipopolysaccharides; Luteolin; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteolysis; RANK Ligand; RAW 264.7 Cells; Skull; Time Factors

2018